Fora Capital, LLC Bausch Health Companies Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $72,916 - $87,534	-2,912 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $434,271 - $517,706	-15,832 Reduced 84.46%	2,912 $85 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $400,559 - $644,418	18,744 New	18,744 $595 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $77,231 - $179,987	-5,950 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $112,395 - $189,745	5,950 New	5,950 $178,000

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.79B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.